DENV Antikörper (pan)

Produktnummer ABIN180831

Produktdetails anti-DENV Antikörper

Target: DENV (Dengue Virus (DENV))

Bindungsspezifität: pan

Reaktivität: Dengue Virus

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser DENV Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Aufreinigung: Affinity Chromatography on Protein A

Klon: Dengue 1-11(3)

Isotyp: IgG2a

Anwendungsinformationen

Applikationshinweise: ELISA. Western Blot (Reducing Conditions). Immunohistochemistry on Paraffin Sections: Requires antigen retrieval using heattreatment prior to staining of paraffin Sections (Sodium citrate buffer pH 6.0 isrecommended for this purpose).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL

Buffer: PBS, pH 7.2, 0.05 % Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Haltbarkeit: 12 months

Details zu DENV

Target: DENV (Dengue Virus (DENV))

Andere Bezeichnung: Dengue Virus (DENV Produkte)

Substanzklasse: Virus

Hintergrund: The dengue virus is responsible for the tropical and sub-tropical diseases, dengue (DF) and dengue haemorrhagic fever (DHF), transmitted to individuals through the bite of the Aedes mosquito. The global distribution of dengue is expanding and comparable to that of malaria, with symptoms ranging from a mild viral syndrome of high fever, rash, headache, fatigue and muscle and joint pain, to the more severe and sometimes fatal DHF. Each dengue virus serotype is antigenically distinct, such that infection only provides an individual with immunity to the causative serotype, with the possibility of further infection by a different serotype or even multiple serotypes.